zidovudine has been researched along with Abnormalities, Autosome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jena, GB; Khan, S; Shekh, K; Yadav, L | 1 |
Bhattacharyya, A; Pandey, BL; Rai, AK; Rajlakshmi, C; Roy, JK | 1 |
González Cid, M; Larripa, I | 1 |
Shelby, MD | 1 |
Beland, FA; Fullerton, NF; Olivero, OA; Poirier, MC | 1 |
Agarwal, RP; Olivero, OA | 1 |
Nokta, MA; Pollard, RB; Shafik, HM | 1 |
Da-Silva-Nunes, O; Durán, N; Haun, M; Mazetto, MN; Pereira-da-Silva, L; Pisani, FJ; Pisani, R; Souza-Brito, AR | 1 |
8 other study(ies) available for zidovudine and Abnormalities, Autosome
Article | Year |
---|---|
Influence of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)polymerase, in the evaluation of the genotoxicity of doxorubicin, cyclophosphamide and zidovudine in female mice.
Topics: Animals; Benzamides; Chromosome Aberrations; Comet Assay; Cyclophosphamide; DNA Damage; Doxorubicin; Endpoint Determination; Female; Liver; Lymphocytes; Mice; Micronucleus Tests; Mutagenicity Tests; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Sucrose; Zidovudine | 2014 |
An unusual phenotypic and genotypic expression in F2 generation following one stage zidovudine exposure during pregnancy and lactation- an experiment in mice.
Topics: Abdominal Fat; Animals; Anti-HIV Agents; Bone Marrow Cells; Chromosome Aberrations; Female; Genes, Recessive; Lactation; Liver; Male; Maternal-Fetal Exchange; Mice; Mutagens; Mutation; Phenotype; Pregnancy; Prenatal Exposure Delayed Effects; Zidovudine | 2012 |
Genotoxic activity of azidothymidine (AZT) in in vitro systems.
Topics: Adult; Analysis of Variance; Animals; Cell Cycle; Cells, Cultured; Chi-Square Distribution; CHO Cells; Chromosome Aberrations; Cricetinae; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Mitotic Index; Mutagenicity Tests; Mutagens; Sister Chromatid Exchange; Zidovudine | 1994 |
The cytogenetic effects of AZT.
Topics: Animals; Antiviral Agents; CHO Cells; Chromosome Aberrations; Cricetinae; Humans; Mice; Micronucleus Tests; Mutagens; Rats; Zidovudine | 1994 |
Vaginal epithelial DNA damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of 3'-azido-2',3'-dideoxythymidine.
Topics: Animals; Cell Division; Chromosome Aberrations; DNA; DNA Damage; Epithelium; Female; Integrin alpha6; Integrins; Mice; Precancerous Conditions; Vagina; Vaginal Neoplasms; Zidovudine | 1994 |
Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine.
Topics: Anti-HIV Agents; Cell Nucleus; Cells, Cultured; Chromosome Aberrations; DNA Adducts; DNA Damage; DNA, Mitochondrial; Humans; Lactic Acid; Lipid Metabolism; Micronuclei, Chromosome-Defective; Mitochondria; Mutagenicity Tests; Radioimmunoassay; T-Lymphocytes; Zidovudine | 1997 |
Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; Chromosome Aberrations; Culture Media; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Recombinant Proteins; Zidovudine | 1991 |
Comparison of the antiviral activity and toxicity of a protein magnesium ammonium phospholinoleate anhydride polymer with other antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Chromosome Aberrations; Female; Humans; Idoxuridine; Lethal Dose 50; Linoleic Acids; Magnesium; Male; Mice; Mitotic Index; Organophosphorus Compounds; Polymers; Viruses; Zidovudine | 1990 |